The Drugs Controller General of India (DCGI) gave approval to molnupiravir for emergency use in the treatment of adult patients with COVID-19 and who have a high risk of disease progression, thus adding another potential drug to the therapeutic armamentarium for the treatment of COVID-19.<br>The oral antiviral pill can be easily taken at home and many experts are of the opinion that it could be a game-changer as it could prevent disease worsening.<br>Join us for an intriguing discussion on this new addition to the COVID-19 therapeutic armamentarium - molnupiravir - where our experts will talk in detail about this antiviral agent and how it can change the current scenario in COVID-19 management.
Dr. Agam Vora
Chest Physician, Vora Clinic, Mumbai & General Secretary, Academy of Advanced Medical Education
Dr. Mangesh Harihar Tiwaskar
Consultant Physician and Diabetologist, Shilpa Medical Research Centre, Mumbai, Honoray General Secretary, Association of Physicians of India (API)
Dr. Gifty Immanuel
MD, PhD, Virologist, Director Center for AIDS and Antiviral Research, Director Medical Division Synergia Pandemic Foundation, Former Director CSIH Hospital, Bangalore
